×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 ... [108]
内容类型
期刊论文 [73]
会议论文 [35]
发表日期
2019 [6]
2018 [14]
2017 [7]
2016 [15]
2015 [23]
2014 [9]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共108条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Efficacy and Safety of Gefitinib as Third-line Treatment in NSCLC Patients With Activating EGFR Mutations Treated With First-line Gefitinib Followed by Second-line Chemotherapy A Single-Arm, Prospective, Multicenter Phase II Study (RE-CHALLENGE,
期刊论文
2019, 卷号: 42, 期号: 5, 页码: 432-439
作者:
Song, Yong
;
Wu, Yi-Long
;
Cao, Le-Jie
;
Chen, Jian-Hua
;
Ma, Zhi-Yong
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2020/01/03
re-challenge
gefitinib
T790M mutation
progression-free survival
EGFR-TKI
NSCLC
Phase II study of antiangiogenic tyrosine kinase inhibitor apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative advanced breast cancer
会议论文
CANCER RESEARCH, 2019-02-01
作者:
Zhu, A.
;
Yuan, P.
;
Wang, J.
;
Fan, Y.
;
Luo, Y.
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2020/01/03
Phase II study of antiangiogenic tyrosine kinase inhibitor apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative advanced breast cancer
期刊论文
2019, 卷号: 79, 期号: 4
作者:
Zhu, A.
;
Yuan, P.
;
Wang, J.
;
Fan, Y.
;
Luo, Y.
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study
期刊论文
2019, 卷号: 37, 期号: 29, 页码: 2610-2619
作者:
Ma Fei
;
Ouyang Quchang
;
Li Wei
;
Jiang Zefei
;
Tong Zhongsheng
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2020/01/03
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial
期刊论文
2019
作者:
Zhu Feng-Cai
;
Hu Shang-Ying
;
Hong Ying
;
Hu Yue-Mei
;
Zhang Xun
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2020/01/03
AS04-HPV-16/18 vaccine
China
efficacy
human papillomavirus
immunogenicity
safety
HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer
期刊论文
2019, 卷号: 131, 页码: 27-34
作者:
Zhai, Yirui
;
Ma, Honglian
;
Hui, Zhouguang
;
Zhao, Lujun
;
Li, Dongming
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2020/01/03
Non-small cell lung cancer
Endostar
Concurrent chemoradiotherapy
Anti-angiogenesis
The Long Term Results of Adding Chemotherapy to Intensity-Modulated Radiation Therapy in the Treatment of Stage II Nasopharyngeal Carcinoma - A Multicenter Phase 2 Study
期刊论文
2018, 卷号: 102, 期号: 3, 页码: S125-S125
作者:
Yi, J.
;
Zhao, C.
;
Chen, X.
;
Gao, L.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer
期刊论文
2018, 卷号: 18, 期号: 1, 页码: 547
作者:
Wang, Guoxiu
;
Zhao, Jiuda
;
Song, Yan
;
Zhang, Wen
;
Sun, Yongkun
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/01/03
Gastric cancer
S-1
Oxaliplatin
Adjuvant chemotherapy
Conversion chemotherapy with capecitabine and oxaliplatin for colorectal cancer with potentially resectable liver metastases: A phase II, open-label, single-arm study
期刊论文
2018, 卷号: 14, 期号: 4, 页码: 772-779
作者:
Li, Yong
;
Li, Guo-Xin
;
Chu, Zhong-Hua
;
Hao, Chun-Yi
;
Jiang, Zhi-Wei
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2020/01/03
Capecitabine plus oxaliplatin
capecitabine
colorectal cancer
liver metastases
oxaliplatin
resection rate
A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome
期刊论文
2018, 卷号: 93, 期号: 6, 页码: 803-809
作者:
Li, Jian
;
Huang, Xu-Fei
;
Cai, Qian-Qian
;
Wang, Chen
;
Cai, Hao
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
©版权所有 ©2017 CSpace - Powered by
CSpace